Saturday, September 5, 2026

AI Chip Testing Giant Forecasts $60-80M Orders as Custom ASIC Demand Surges

Aehr Test Systems projects $60-80M in bookings for the second half of FY2026, driven by AI chip burn-in testing demand. The company secured orders for high-power Sonoma systems capable of testing devices at 2,000 watts, with a lead customer forecasting shipments starting Q1 FY2027.

AI Chip Testing Giant Forecasts $60-80M Orders as Custom ASIC Demand Surges
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Aehr Test Systems received a "very large forecast" from a lead AI ASIC customer, with production shipments expected to begin in Q1 FY2027. The testing equipment maker projects $60-80M in bookings for the fiscal second half ending May 2026, primarily from AI wafer-level and packaged-part burn-in systems.

The company shipped multiple Sonoma system configurations supporting up to 2,000 watts per device. Q3 Sonoma orders hit $5.5M to date, exceeding the entire Q2 total of $6.2M. Aehr claims production capacity exceeds 20 systems monthly for both wafer and package-level testing.

NVIDIA's dominance with Hopper and upcoming Blackwell architectures continues to drive specialized testing infrastructure demand. Competitors like SambaNova pursue alternative architectures with Reconfigurable Dataflow Units, while the broader ecosystem addresses computational bottlenecks from multiple angles.

Samsung's HBM3e memory advances target the "memory wall" challenge limiting AI performance. Amkor expanded semiconductor packaging capacity in Arizona, reflecting supply chain shifts for advanced AI chips. Ensurge developed microbatteries for AI-enabled edge devices, extending the hardware stack to power-constrained deployments.

Aehr's Q2 FY2026 revenue fell 27% year-over-year to $9.9M, with non-GAAP gross margin dropping to 29.8% from 45.3%. The company delayed ~$2M in WaferPak shipments for gallium nitride customers from Q2 to Q3 due to high-voltage protection circuit redesigns.

The company raised $10M through an at-the-market equity offering in Q2, selling 384,000 shares. Cash position improved to $31M from $24.7M the previous quarter, with $30M remaining under a $40M ATM program.

Aehr expanded its partnership with ISE Labs and ASE for wafer-level and packaged-part testing services targeting top-tier semiconductor customers in HPC and AI applications. The Silicon Valley test lab received multiple orders for new high-power configurations.

Second-half guidance projects $25-30M revenue with a non-GAAP net loss of $0.09-$0.05 per share. The company expects minimal silicon carbide contribution, focusing bookings on AI-related burn-in testing as custom chip development accelerates across hyperscalers and AI startups.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score8 source documents8 with a live linkVerifiability: High
  1. [1]Earnings callNasdaq· January 16, 2026
    Aehr Test (AEHR) Q2 2026 Earnings Call Transcript
  2. [2]News articleYahoo Finance· December 1, 2025
    Credo Technology Group Holding Ltd Reports Second Quarter of Fiscal Year 2026 Financial Results
  3. [3]News articleYahoo Finance· February 10, 2026
    Einride to Appoint Former NVIDIA Executive Gary Hicok to Board of Directors
  4. [4]Press releaseGlobeNewswire· December 5, 2025
    Ensurge Micropower ASA – Commencement of subscription period in the Subsequent Offering
  5. [5]Press releaseGlobeNewswire· November 6, 2025
    Ensurge Micropower ASA – Contemplated private placement
  6. [6]News articleYahoo Finance· December 5, 2025
    Stock market today: S&P 500, Nasdaq, Dow rise as Fed-favored PCE inflation data cools
  7. [7]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq end higher in volatile trading day as Apple jumps
  8. [8]Press releaseGlobeNewswire· December 11, 2025
    Wafer Dicing Services Market Set to Exceed US$ 932.9 Million by 2035 | Astute Analytica
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com